MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma-Reference-Cited by-同舟云学术

MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma

Published:2018-05-01 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Zingoni Alessandra,Vulpis Elisabetta,Cecere Francesca,Amendola Maria G.,Fuerst Daniel,Saribekyan Taron,Achour Adnane,Sandalova Tatyana,Nardone Ilaria,Peri Agnese,Soriani Alessandra,Fionda Cinzia,Mariggiò Elena,Petrucci Maria T.,Ricciardi Maria R.,Mytilineos Joannis,Cippitelli Marco,Cerboni Cristina,Santoni Angela

Funder

Associazione Italiana per la Ricerca sul Cancro

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. NKG2D receptor and its ligands in host defense;Lanier;Cancer Immunol Res,2015

2. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis;Cerboni;Blood,2007

3. NKG2D ligands in tumor immunity;Nausch;Oncogene,2008

4. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes;Ashiru;Cancer Res,2010

5. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family;Steinle;Immunogenetics,2001

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and function of the major histocompatibility complex (MHC) class I chain-related A (MICA)*010 in NK cell killing activity;Human Immunology;2024-09

2. A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review);Oncology Reports;2024-08-14

3. Targeting NKG2D/NKG2DL axis in multiple myeloma therapy;Cytokine & Growth Factor Reviews;2024-04

4. The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes;Biomedicines;2024-01-16

5. MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT;Archivum Immunologiae et Therapiae Experimentalis;2024-01-01